EPS (Diluted) for DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's current diluted EPS (TTM) is $2.09. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DXCM
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$2.09
YoY change
+47.2%
5Y CAGR
+10.5%
Peak year (2025)
$2.09
Latest annual
$2.09
EPS (Diluted) history chart for DexCom (DXCM) from 2000 to 2025
EPS (Diluted) history table for DexCom (DXCM) from 2000 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $2.09 | +47.2% | ||
| 2024 | $1.42 | +9.2% | ||
| 2023 | $1.30 | +62.5% | ||
| 2022 | $0.80 | +56.9% | ||
| 2021 | $0.51 | -59.8% | ||
| 2020 | $1.27 | +370.4% | ||
| 2019 | $0.27 | -175.0% | ||
| 2018 | $-0.36 | +140.0% | ||
| 2017 | $-0.15 | -25.0% | ||
| 2016 | $-0.20 | +11.1% | ||
| 2015 | $-0.18 | +141.6% | ||
| 2014 | $-0.07 | -25.5% | ||
| 2013 | $-0.10 | -50.0% | ||
| 2012 | $-0.20 | +17.6% | ||
| 2011 | $-0.17 | -29.2% | ||
| 2010 | $-0.24 | -20.0% | ||
| 2009 | $-0.30 | -36.2% | ||
| 2008 | $-0.47 | +14.6% | ||
| 2007 | $-0.41 | -4.7% | ||
| 2006 | $-0.43 | +4.9% | ||
| 2005 | $-0.41 | -73.2% | ||
| 2004 | $-1.53 | +34.2% | ||
| 2003 | $-1.14 | +21.3% | ||
| 2002 | $-0.94 | +13.3% | ||
| 2001 | $-0.83 | +45.6% | ||
| 2000 | $-0.57 | — |
EPS (Diluted) values are taken from DexCom's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, DexCom (DXCM) reported diluted EPS of $2.09 – surged 47.2% year-over-year.
Through 2020–2025 (5 years), DexCom diluted EPS delivered a +10.5% annualised rate; sustaining 4 straight years of year-over-year growth.
The highest annual diluted EPS of $2.09 was reported in 2025. The lowest in the available history was $-1.53 in 2004.
DexCom (DXCM) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
DexCom EPS (Diluted) by Year
DexCom EPS (Diluted) 2025: $2.09
DexCom diluted EPS in 2025 was $2.09, surged 47.2% from 2024. This figure represents the highest annual value in the available history.
DexCom EPS (Diluted) 2024: $1.42
DexCom diluted EPS in 2024 was $1.42, grew 9.2% from 2023.
DexCom EPS (Diluted) 2023: $1.30
DexCom diluted EPS in 2023 was $1.30, surged 62.5% from 2022.
DexCom EPS (Diluted) 2022: $0.80
DexCom diluted EPS in 2022 was $0.80, surged 56.9% from 2021.
DexCom EPS (Diluted) 2021: $0.51
DexCom diluted EPS in 2021 was $0.51.
See more financial history for DexCom (DXCM).
Sector peers — EPS (Diluted)
Companies in the same sector as DexCom, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is DexCom's diluted EPS?
- Latest reported diluted EPS for DexCom (DXCM) is $2.09 (period ending December 31, 2025).
How has DexCom diluted EPS changed year-over-year?
- DexCom (DXCM) diluted EPS changed +47.2% year-over-year on the latest annual filing.
What is the long-term growth rate of DexCom diluted EPS?
- DexCom (DXCM) diluted EPS compound annual growth rate is +10.5% over the most recent 5 years available.
When did DexCom diluted EPS hit its highest annual value?
- DexCom diluted EPS reached its highest annual value of $2.09 in 2025.
What was DexCom diluted EPS in 2024?
- DexCom (DXCM) diluted EPS in 2024 was $1.42.
What was DexCom diluted EPS in 2025?
- DexCom (DXCM) diluted EPS in 2025 was $2.09.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DXCM Overview
Company profile, financial tools, and key metrics
DXCM Revenue Counter
Earns $147.83 every second. See per minute, hour, and day.
DXCM Earnings Counter
Earns $26.52 per second net profit. See per minute, hour, and day.
DXCM Economic Scale
Exceeds Suriname's GDP. Compare with world economies.
DXCM What If Invested
What if you had invested $1,000? See historical returns from any date.
DXCM How It Makes Money
Discover visual breakdown of $4.66B in revenue — where it comes from and where it goes.
DXCM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DXCM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DXCM Daily Price Character
Explosive · 49.4% historical win rate (green days). Streaks & record days.
DXCM Buybacks
1.95% TTM buyback yield. Shareholder yield & SBC comparison.
DXCM Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.